$BVXV

Biondvax Pharmaceuticals Ltd

  • NASDAQ
  • Health Technology
  • Pharmaceuticals: Major
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$1.17 β–²0.429%

Last Close

VOLUME

32,904

DAY RANGE

1.13 - 1.19

52 WEEK

1 - 4.19

Join Discuss about BVXV with like-minded investors

profile
@maletone #StockTraders.NET
recently

covered some $BVXV

112 Replies 8 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

hopefully we get a real nice push on $BVXV to re short

48 Replies 15 πŸ‘ 10 πŸ”₯

profile
@Baljit123 #StockTraders.NET
recently

IMPP - Not too in love with this. Mayb 2.20 / 2.40 / 2.60 pop to scale into short with a 2.80 STOP ALLG - Potential HOT CHICK runner of the day. If shorting, Ultimate stop has to be above 24. Maybe a quick nail and bail short 21 / 22 to scale in short 30% size only CELZ - Looking for 3.50 / 3.70 / 4.00 pop with a 4.15 STOP NKLA - This is a cult stock. So it might go further than we think. So let this TOP OUT FIRST then we can short the bounce AMC - Looking for a push to scale in short 20.70 / 21.00 / 21.50 in the morning GME - 2 potential trades here. Looking for a r/g rejection to short or if it dumps at the open, triggers ssr, will look to short that SSR bounce. DO NOT chase weakness here MFH - Feels like one that can halt up on air. So waiting for it to TOP OUT first then will join bounces to short BVXV - Potential HOT CHICK. Avoiding short for now https://myinvestingclub.com/trading/when-to-use-max-size-full-size-in-the-stock-market-sizing-explained-in-detail-w-alex-temiz/

143 Replies 6 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

watching $BVXV, $MFH, $CELZ, $MULN\

91 Replies 10 πŸ‘ 13 πŸ”₯

profile
@Baljit123 #StockTraders.NET
recently

BFRI - Looking to short a bounce 11.30 / 11.50 / 11.70 / 12.00 lines BVXV - Looking for a bounce to VWAP / 3.50 to short MBOT - 8.50 / 9.00 lines in the morning to scale in short RELI - HOT CHICK. Ignoring it for now short side https://myinvestingclub.com/trading/how-to-scale-into-the-watch-list-when-to-use-max-full-size-when-trading-30-rule-watch-list/

46 Replies 15 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

would be nice if $BVXV ran some

116 Replies 7 πŸ‘ 14 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

looks like will be another quiet day for me...no borrows on any of the gappers: $BVXV, $RELI, $SPRB and $MBOT

103 Replies 12 πŸ‘ 14 πŸ”₯

SO
@soheil.n #StockTraders.NET
recently

TTM Watchlist: $ENSC reactionary, its multiday runner by now. 7 mil float. $BVXV potential for 30-40c fade today $GRTX long bias 4,70 target $SOPA multiday runner $KXIN if gets higher Current cycle: Strong but mixed performances split across two themes.

64 Replies 8 πŸ‘ 6 πŸ”₯

profile
@Baljit123 #StockTraders.NET
recently

BVXV - Low hanging fruit. Looking for a pop toward 2.80 /3.00 / 3.10 to short SEAC - 2.30 / 2.50 / 2.70 lines to short BFRI - Looking to short 11.50 / 12.00. NAIL AND BAIL ONLY ENSC - LET THIS TOP OUT FIRST then we will attack. More commentary at open SOPA - Looking for a morning pop toward 17.00 for a nail and bai ONLY https://myinvestingclub.com/trading/how-to-scale-into-the-watch-list-when-to-use-max-full-size-when-trading-30-rule-watch-list/

74 Replies 9 πŸ‘ 15 πŸ”₯

profile
@Baljit123 #StockTraders.NET
recently

BRTX LHF - ideally we get 5.5 6 6.5 to scale into stop would be over 6.5 but doubt it will get there RCAT LHF - not much meat left so i dont like much but if you want 2.4 - 2.8 stop over prev HOD AVCT LHF - 2.4 - 2.8 as well stop over 2.8 as it was prev HOD BVXV LHF - 3 - 3.5 area for me stop over 3.5

117 Replies 10 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

calling it a day: on watch: $BVXV, $SEAC, $ARDS, $AVCT, $GNFT, $SOFA

42 Replies 14 πŸ‘ 7 πŸ”₯

AL
@albertoc #StockTraders.NET
recently

I was on the phone and couldn't alert live but got a small piece short on $BVXV

127 Replies 13 πŸ‘ 7 πŸ”₯

profile
@Baljit123 #StockTraders.NET
recently

BRTX - Looking for a morning pop toward 6.50 / 6.70 / 7.00 to short. This is ETB. So it can zombie later SOPA - Looking for a pop toward 10.60 / 11 / 11.50 to scale in short RCAT - 2.60 / 2.70 / 2.80 lines to scale in short BVXV - HOT CHICK of the day so will AVOID the short for now BFRI - Patiently waiting on this one. Might be a 12.00 / 12.50 rejection before we see this melt lower https://myinvestingclub.com/trading/how-to-scale-into-the-watch-list-when-to-use-max-full-size-when-trading-30-rule-watch-list/

101 Replies 15 πŸ‘ 11 πŸ”₯

BR
@brAli #StockTraders.NET
recently

wou;d be nice if BVxv can get up too vwap for reshort

77 Replies 11 πŸ‘ 14 πŸ”₯

WI
@WINTERTRADE #StockTraders.NET
recently

$btbt $bvxv $grvi for me

48 Replies 8 πŸ‘ 14 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$bvxv main watch for me

62 Replies 13 πŸ‘ 7 πŸ”₯

profile
@maletone #StockTraders.NET
recently

covered some more $BVXV 3.40

91 Replies 12 πŸ‘ 13 πŸ”₯

profile
@maletone #StockTraders.NET
recently

nice on $BVXV chasers burnt

147 Replies 11 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

watch list for tomorrow: $NNVC, $BVXV, $INTZ, $XBIO, $DYAI add: $SPRT to the list

66 Replies 14 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$BVXV is an atlas pump

96 Replies 8 πŸ‘ 6 πŸ”₯

profile
@maletone #StockTraders.NET
recently

watch list for tomorrow: $nnvc, $bvxv, $INTZ, $xbio, $DYAI

112 Replies 9 πŸ‘ 15 πŸ”₯

profile
@maletone #StockTraders.NET
recently

$BVXV on watch

56 Replies 14 πŸ‘ 11 πŸ”₯

Key Metrics

Market Cap

13.28 M

Beta

1.37

Avg. Volume

41.15 K

Shares Outstanding

11.35 M

Yield

0%

Public Float

0

Next Earnings Date

Next Dividend Date

Company Information

BiondVax Pharmaceuticals Ltd. is a biopharmaceutical company focused on development and manufacturing of products for the prevention of infectious diseases. The Company had been developing M 001, a novel flu vaccine candidate that was designed to provide multi-strain and multi-season protection against current and future, seasonal and pandemic influenza. In seven Phase 1/2 and Phase 2 clinical trials designed to test for immunogenicity, the Company was able to demonstrate M-001 was effective in stimulating an immune response to a broad range of flu strains. In October 2020, the Company completed a Phase 3 clinical trial of M 001 which failed to meet the trial’s primary and secondary efficacy endpoints. The company is now pursuing opportunities in the infectious disease space, including exploring several alternatives for development of a pipeline of assets.

CEO: Ron Babecoff

Website:

HQ: Weizmann Science Park Po Box 4143 14 Einstein Street, 7403618 Ness Ziona

Related News